Know the COVOVAX vaccine from India. Thailand has donated 2 hundred thousand doses. Who has a plan to inject it for?

Anything generally related to the field as a whole, its community, or anything not relevant to any other category can go here.
Forum rules
Pretty similar to the Discord, overall. Not on the Discord? Join it here!
Post Reply
Posts: 87
Joined: Sun Sep 12, 2021 10:43 am


On April 21, 2022, reporters reported that Thailand receives COVOVAX COVID-19 vaccine from IndiaSLOTXOThrough the Ministry of Foreign Affairs, amounting to 20 thousand bottles, totaling 2 hundred thousand doses, worth 60 million rupees, under the support of the Quadrilateral Security Dialogue or QUAD (Quadrilateral Security Dialogue) to support and promote Thailand's public health system. To accelerate the immunization of people with vaccines to reduce the impact of the COVID-19 crisis

"National Business" collects information about COVOVAX vaccine, which is a vaccine that the Department of Medical Sciences is in the process of certifying the production version. When completed, it will be distributed and used further.

Subunit protein vaccine
The COVOVAX vaccine is a protein subunit type. It is in the process of certifying the production version before further use. It will focus on those who have never been vaccinated before.

Dr. Opas Karnkawinpong, MD. Director-General of the Department of Disease Control said that the COVOVAX vaccine is a protein subunit vaccine. Around the world, this type of vaccine is still rarely used. The academic committee therefore agreed to use it according to the label, that is, 2 injections 3 weeks apart, and recommended that the injection be given to those who have not been vaccinated before or who are allergic to other vaccines. at the discretion of the physician As for its use as a stimulant, it still needs to be studied.

Not enough to protect Omikron?
Dr. Anan Chongkaewwatana, virologist Director of Animal Health and Management Innovation Research Group National Center for Genetic Engineering and Biotechnology (Bio-Tech), National Science and Technology Development Agency (NSTDA) posted on Facebook that

COVOVAX is the same vaccine as NOVAVAX manufactured in India. Using technology that Novavax conveys to produce and use in low to middle income countries. Is it like 100% Novavax or not, you need to see details, but the results from Novavax that come out 2 needles are still not enough to prevent Omikron. as with other vaccines

COVOVAX is for use in the age group of 12-18 years in India.
The COVOVAX vaccine, developed by US company Novavax, Inc., is the second anti-COVID vaccine produced by the Serum Institute of India (SII), India's main vaccine manufacturer. which produces Oxford-AstraZeneca's coronavirus vaccine under the brand name "Cowi Shield".

The Drugs Control Agency of India (DCGI) has approved "COVOVAX", the second SII coronavirus vaccine for emergency use in adolescents aged 12 to 18 years.
Post Reply